Skip to content

Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)

Evaluation of Distal Esophageal and Cardia Rubber Band Ligation and Mucosectomy in the Treatment of Subjects With Gastroesophageal Reflux Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01199679
Acronym
GERD
Enrollment
10
Registered
2010-09-13
Start date
2011-06-30
Completion date
2013-03-31
Last updated
2015-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease, Heartburn, Regurgitation, Dyspepsia

Keywords

Gastroesophageal Reflux Disease, Heartburn, Regurgitation, Dyspepsia

Brief summary

The purpose of this study is to determine the safety and effectiveness of two separate procedures to treat gastroesophageal reflux disease (GERD) also known as heartburn. The two therapies are: 1) a banding procedure alone using the Cook® 6 Shooter™ Saeed Multi-Band Ligator or 2) a banding/shaving procedure called Endoscopic Mucosal Resection (EMR) using the Cook® Duette™ Multi-Band Mucosectomy device.

Interventions

PROCEDUREMucosectomy

Endoscopic mucosal resection in the upper GI tract.

Endoscopically ligate esophageal varices at or above the gastroesophageal junction or to ligate internal hemorrhoids.

Sponsors

Cook Group Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is 18 years of age or older. * Typical symptoms of heartburn and/or regurgitation requiring daily PPI therapy. * Subject agrees to participate and signs consent form.

Exclusion criteria

* Patient is pregnant. * Patient has a hiatal hernia greater than 2cm. * Presence of persistent daily solid food dysphagia, unplanned weight loss over ten pounds, esophageal bleeding, or vomiting more than once per week). * Active medical condition that would preclude the subject from finishing this study. * BMI \> 39.

Design outcomes

Primary

MeasureTime frameDescription
Reduction of reflux symptoms measured by GERD HRQL6 monthsHRQL = Health Related Quality of Life Questionnaire

Secondary

MeasureTime frame
Reduction in total esophageal acid exposure measured by 48 hour pH monitoring6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026